Search Results - "Vallejo, Carlos"

Heterogeneous Fenton oxidation of phenol photo-assisted with visible radiation in the presence of g-C3N4 catalysts modified with different iron phases by Burbano, Evelyn Alejandra, Vallejo, Carlos Andrés, Ramirez, Juan David, Hidalgo-Troya, Arsenio, Galeano, Luis Alejandro

“…[Display omitted] •Iron-doped-g-C3N4 exhibits remarkable mineralization of phenol at circumneutral pH.•Fe in the framework of g-C3N4 is an excellent…”
Get full text

Multidimensional forecasting of precipitation and potential evapotranspiration in the Paranapanema river basin using neural network time series by Mendez Vallejo, Carlos Andres, Lilla Manzione, Rodrigo

“…Spatial and temporal forecasts of the hydrological cycle compartments aiming projections of extreme drought scenarios represent a challenge for the planning,…”
Get full text

Operational excellence in online food delivery service: the role of food biosafety measures by Chinelato, Flavia Braga, Hoyos Vallejo, Carlos Arturo

“…Purpose This study explores how food biosafety measures (FBM), electronic service quality and product quality influence consumer satisfaction and loyalty in…”
Get full text

Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade by Avila, Jorge, Leone, Julieta, Vallejo, Carlos T., Lin, Nancy U., Leone, José P.

“…Purpose There have been significant advances in the treatment of metastatic breast cancer (BC) over the past years, and long-term outcomes after a diagnosis of…”
Get full text

Preparation of Al/Fe-PILC clay catalysts from concentrated precursors: enhanced hydrolysis of pillaring metals and intercalation by Vallejo, Carlos Andrés, Galeano, Luis Alejandro, Trujillano, Raquel, Vicente, Miguel Ángel, Gil, Antonio

“…The modification of bentonite with Al-Fe species from different concentrated precursors at both stages: (i) the preparation of the (Al/Fe)-mixed pillaring…”
Get full text

Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis by Leone, Bernardo Amadeo, Vallejo, Carlos Teodoro, Romero, Alberto Omar, Machiavelli, Mario Raúl, Pérez, Juan Eduardo, Leone, Julieta, Leone, José Pablo

“…Purpose To analyze the prognostic influence of metastatic pattern (MP) compared with other biologic and clinical factors in stage IV breast cancer at initial…”
Get full text

Locoregional treatment and overall survival of men with T1a,b,cN0M0 breast cancer: A population-based study by Leone, José Pablo, Leone, Julieta, Zwenger, Ariel Osvaldo, Iturbe, Julián, Leone, Bernardo Amadeo, Vallejo, Carlos Teodoro

“…Abstract Background Male breast cancer (MaBC) is an understudied disease; information about locoregional treatment and outcomes in patients with early stage is…”
Get full text

Tumor subtypes and survival in male breast cancer by Leone, Julieta, Freedman, Rachel A., Lin, Nancy U., Tolaney, Sara M., Vallejo, Carlos T., Leone, Bernardo A., Winer, Eric P., Leone, José Pablo

“…Purpose Male breast cancer is an uncommon disease, and population-based information regarding prognostic factors is limited. Most cases are hormone receptor…”
Get full text

Quality of Leadership and Organizational Climate in a Sample of Spanish Workers. The Moderation and Mediation Effect of Recognition and Teamwork by Pérez-Vallejo, Carlos, Fernández-Muñoz, Juan José

“…The purpose of this study is to analyze the relationships between the quality of leadership, achievement recognition, and teamwork with the organizational…”
Get full text

Efficacy of neoadjuvant chemotherapy in male breast cancer compared with female breast cancer by Leone, José Pablo, Hassett, Michael J., Leone, Julieta, Tolaney, Sara M., Vallejo, Carlos T., Leone, Bernardo A., Winer, Eric P., Lin, Nancy U.

“…Background Neoadjuvant chemotherapy (NAC) is standard for many females with breast cancer (FBC). The efficacy of NAC in male breast cancer (MaBC) is unclear…”
Get full text

Survival in male breast cancer over the past 3 decades by Leone, José P, Freedman, Rachel A, Leone, Julieta, Tolaney, Sara M, Vallejo, Carlos T, Leone, Bernardo A, Winer, Eric P, Lin, Nancy U, Hassett, Michael J

“…Abstract Background Breast cancer mortality in women has declined statistically significantly over the past several years. In men, it is unclear whether…”
Get full text

Peri-event plasma PCSK9 and hsCRP after an acute myocardial infarction correlate with early deterioration of left ventricular ejection fraction: a cohort study by Silva-Bermúdez, Lina S, Vargas-Villanueva, Andrea, Sánchez-Vallejo, Carlos A, Palacio, Ana C, Buitrago, Andrés F, Mendivil, Carlos O

“…Abstract Background It is important to identify patients at increased risk of worsening of left ventricular ejection fraction (LVEF) after a myocardial…”
Get full text

Estimating mortality in women with triple-negative breast cancer: The ‘ESTIMATE triple-negative’ tool by Leone, José P., Graham, Noah, Leone, Julieta, Tolaney, Sara M., Leone, Bernardo A., Freedman, Rachel A., Hassett, Michael J., Vallejo, Carlos T., Winer, Eric P., Lin, Nancy U., Tayob, Nabihah

“…Triple-negative breast cancer (TNBC) is associated with a high risk of breast cancer-specific mortality (BCSM). Estimating the risk of BCSM and non-BCSM in…”
Get full text

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort by Rodríguez-Ariza, Carlos Daniel, Cabrera-Villamizar, Alfredo, Rodríguez-Pulido, Astrid Lorena, Callegari, Santiago, Ossa Rodríguez, Natalia Alejandra, Pinilla-Roncancio, Mónica, Moreno López, Sergio Mauricio, Sánchez-Vallejo, Carlos Andrés

“…No cardiovascular risk score has included Latin American patients in its development. The ACC/AHA ASCVD risk score has not been validated in Latin America;…”
Get full text

Estimating long-term mortality in women with hormone receptor-positive breast cancer: The ‘ESTIMATE’ tool by Leone, José P., Graham, Noah, Tolaney, Sara M., Leone, Bernardo A., Freedman, Rachel A., Hassett, Michael J., Leone, Julieta, Vallejo, Carlos T., Winer, Eric P., Lin, Nancy U., Tayob, Nabihah

“…The risk of breast cancer-specific mortality (BCSM) persists for at least 20 years from diagnosis. Estimating the risk of BCSM over this extended period along…”
Get full text

Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis by Leone, José Pablo, Leone, Julieta, Zwenger, Ariel Osvaldo, Iturbe, Julián, Leone, Bernardo Amadeo, Vallejo, Carlos Teodoro

“…Abstract Background The presence of brain metastases at the time of initial breast cancer diagnosis (BMIBCD) is uncommon. Hence, the prognostic assessment and…”
Get full text

Factors associated with late risks of breast cancer-specific mortality in the SEER registry by Leone, José P., Vallejo, Carlos T., Hassett, Michael J., Leone, Julieta, Graham, Noah, Tayob, Nabihah, Freedman, Rachel A., Tolaney, Sara M., Leone, Bernardo A., Winer, Eric P., Lin, Nancy U.

“…Purpose Most reports describing the risk of late relapse in breast cancer (BC) have been based on selected patients enrolled into clinical trials. We examined…”
Get full text

DECISION-MAKING AND EFFECTIVENESS OF BUSINESS RESULTS IN TIMES OF COVID-19 by Hoyos-Vallejo, Carlos Arturo

“…Managers often make decisions in organizations without being aware of the results and hence, their effectiveness. I evaluated three decisions managers made…”
Get full text

Prognostic factors in male breast cancer: a population-based study by Leone, José Pablo, Zwenger, Ariel Osvaldo, Iturbe, Julián, Leone, Julieta, Leone, Bernardo Amadeo, Vallejo, Carlos Teodoro, Bhargava, Rohit

“…Prognostic factors in male breast cancer (MaBC) are controversial. The objective of this study was to analyze patient characteristics and prognostic factors in…”
Get full text

Eltrombopag for the treatment of poor graft function following allogeneic stem cell transplant: a retrospective multicenter study by Giammarco, Sabrina, Sica, Simona, Chiusolo, Patrizia, Laurenti, Luca, Sorá, Federica, Martino, Massimo, Metafuni, Elisabetta, Busca, Alessandro, Risitano, Antonio, Vallejo, Carlos, Bacigalupo, Andrea

“…This retrospective study assessed the effectiveness of eltrombopag (EPAG), a thrombopoietin receptor agonist, in the treatment of poor graft function (PGF)…”
Get full text